Non-clinical safety studies for biotechnologically-derived pharmaceuticals: conclusions from an international workshop

被引：3

作者：

Griffiths, SA ^{[1
]}

Lumley, CE ^{[1
]}

机构：

[1] Ctr Med Res Inst, Carshalton SM5 4DS, Surrey, England

来源：

HUMAN & EXPERIMENTAL TOXICOLOGY | 1998年 / 17卷 / 02期

关键词：

biotechnology; non-clinical; safety evaluation; pharmaceutical;

D O I：

10.1191/096032798678908341

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

[No abstract available]

引用

页码：63 / 83

页数：21

共 24 条

[1]

ANARI MR, 1995, DRUG METAB DISPOS, V23, P536

[2]

ANDERSON TD, 1993, INT REV EXP PATHOL, V34, P57

[3]

ANDERSON TD, 1993, INT REV EXP PATHOL, V34, P9

[4]

CRIBB AE, 1994, J PHARMACOL EXP THER, V268, P487

[5]

GRIFFITHS SA, 1997, SAFETY EVALUATION BI

[6]

GRIFFITHS SA, 1995, CMR9563R

[7] IL-12 AT THE CROSSROADS [J].

HALL, SS .

HAYES, TJ ;

CAVAGNARO, JA .

Hayes, TJ ;

Ryffel, B .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 83 (01) :1-4

[10]

LIPANI J, 1997, SAFETY EVALUATION BI